Margetuximab, is a chimeric IgG monoclonal antibody medication against HER2 used for the treatment of cancer.<\/p>\n
The most common adverse drug reactions in combination with chemotherapy are fatigue\/asthenia, nausea, diarrhea, vomiting, constipation, headache, pyrexia, alopecia, abdominal pain, peripheral neuropathy, arthralgia\/myalgia, cough, decreased appetite, dyspnea, infusion-related reactions, palmar-plantar erythrodysesthesia, and extremity pain. Margetuximab is indicated, in combination with chemotherapy, for the treatment of adults with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease.<\/p>\n
To access margetuximab-cmkb injection sold under the brand name can be made available on request to patient if the drug has not been approved or is not available in your country. For information or advice, call IPN’s Pharmaceutical Expert. Our expert will be happy to take your query and guide with an effective solution. Be free and call today for full support at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n
Margenza (margetuximab-cmkb injection) for intravenous use Initial U.S. approval: 2020<\/p>\n","protected":false},"excerpt":{"rendered":"
Margenza (margetuximab-cmkb) is a medication used in combination with chemotherapy, to treat adults with metastatic HER2-positive breast cancer after at least two previous rounds of therapy.<\/p>\n
Disease Indications-Breast Cancer If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cmargetuximab-cmkb injection\u201d based on the information you provide.<\/p>\n
\nManufacturer-MacroGenics
\nUsage-Intravenous
\nMedicine Approved By-Food and Drug Administration (FDA)
\nSummary of FDA-approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n